发明授权
- 专利标题: Treatment of bipolar disorder
- 专利标题(中): 治疗双相情感障碍
-
申请号: US13983011申请日: 2012-01-18
-
公开(公告)号: US08901158B2公开(公告)日: 2014-12-02
- 发明人: Grant C. Churchill , Sridhar R. Vasudevan , Nisha Singh
- 申请人: Grant C. Churchill , Sridhar R. Vasudevan , Nisha Singh
- 申请人地址: GB Oxford
- 专利权人: Isis Innovation Ltd.
- 当前专利权人: Isis Innovation Ltd.
- 当前专利权人地址: GB Oxford
- 代理机构: Wood, Phillips, Katz, Clark & Mortimer
- 优先权: GB1102248.0 20110209
- 国际申请: PCT/GB2012/050105 WO 20120118
- 国际公布: WO2012/107735 WO 20120816
- 主分类号: A61K31/428
- IPC分类号: A61K31/428 ; A61K31/416 ; A61K31/41 ; A61K45/06 ; C07D275/04 ; C07D293/12
摘要:
The invention relates to sulphur- and/or selenium-containing compounds that can inhibit the enzyme inositol mono-phosphatase (IMPase), and which can be used in treating conditions that are treatable through inhibition of this enzyme, such as bi-polar disorder, the compounds having a structure of Formula (I), or is a pharmaceutically acceptable salt thereof; Formula (I); in which: E is S or Se and each of phenyl rings A and B is optionally substituted with one or more substituents, in which each substituent is selected independently from: (1) a halogen, which is preferably selected from F, Cl and Br; (2) C1-C4 alkyl, such as C1-C2 alkyl or C1 alkyl, optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br; and (3) C1-C4 alkoxy, such as C1-C2 alkoxy or C1 alkoxy; optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br.
公开/授权文献
- US20140094449A1 TREATMENT OF BIPOLAR DISORDER 公开/授权日:2014-04-03
信息查询
IPC分类: